![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/04/2892776/0/en/ExeVir-Bio-Announces-Exceptional-Virus-Neutralization-Potency-of-its-Variant-proof-XVR013m-Antibody-Against-the-SARS-CoV-2-Variant-JN-1.html
https://www.globenewswire.com//news-release/2024/01/15/2808967/0/en/ExeVir-Bio-Announces-Positive-Virus-Neutralization-Data-for-XVR012-Against-Emerging-COVID-19-Omicron-Variants.html
https://www.globenewswire.com/news-release/2023/06/28/2695913/0/en/ExeVir-Bio-Awarded-EUR-1-6m-Grant-for-Dengue-Research.html
https://www.globenewswire.com/news-release/2023/03/13/2625442/0/en/ExeVir-Bio-and-VIB-Announce-Data-on-a-New-Therapy-for-Prevention-and-Treatment-for-COVID-19.html
https://www.globenewswire.com/news-release/2023/01/09/2584805/0/en/ExeVir-Bio-secures-EUR-25-million-venture-debt-financing-from-the-European-Investment-Bank.html
https://www.prnewswire.com/news-releases/exevir-bio-forges-ahead-with-unique-next-generation-covid-19-therapy-and-appoints-dr-jeanne-bolger-as-chair-of-the-board-of-directors-301654004.html
https://endpts.com/scoop-exevir-hits-pause-on-llama-derived-covid-antibody-amid-omicron-variants-shifts-focus-to-second-gen-work/
https://www.prnewswire.com/news-releases/exevir-announces-first-patient-enrolled-in-phase-1b2-clinical-study-evaluating-xvr011-as-antiviral-treatment-of-patients-hospitalised-for-covid-19-301366722.html
https://endpts.com/covid-19-roundup-exevir-pushes-llama-antibody-into-the-clinic-with-healthy-volunteer-study/
https://www.contractpharma.com/contents/view_breaking-news/2021-07-20/exevir-mithra-cdmo-enter-manufacturing-collaboration/?widget=listSection